| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 9, 2026 | CERS Cerus Corporation | Benjamin Richard J71 | Chief Medical Officer | Sell | 125,894 | $1.99 | $250,931.66 | -4.4% | +40.1% | - | |
| Mar 9, 2026 | CERS Cerus Corporation | Benjamin Richard J71 | Chief Medical Officer | Sell | 125,894 | $1.99 | $250,937.78 | -4.4% | +40.1% | - | |
| Mar 9, 2026 | PRCT Procept Biorobotics Corporation | Desai Antal Rohit82 | Director | Buy | 426,262 | $24.59 | $10,482,942.96 | +25.0% | +6.9% | - | |
| Mar 6, 2026 | IRIX Iridex Corporation | Dizon Romeo R64 | Chief Financial Officer | Buy | 1,110 | $1.26 | $1,398.60 | +0.9% | -9.8% | - | |
| Mar 6, 2026 | CERS Cerus Corporation | Jensen Chrystal71 | Chief Legal Officer | Sell | 30,845 | $2.01 | $61,859.65 | -2.8% | +43.8% | - | |
| Mar 6, 2026 | CERS Cerus Corporation | Jayaraman Vivek K67 | Chief Operating Officer | Sell | 34,094 | $2.01 | $68,375.52 | -1.8% | +43.8% | - | |
| Mar 6, 2026 | CERS Cerus Corporation | Greenman William Mariner70 | President And CEO | Sell | 78,187 | $2.01 | $156,804.03 | -1.4% | +43.8% | - | |
| Mar 6, 2026 | CERS Cerus Corporation | Green Kevin Dennis71 | Chief Financial Officer | Sell | 83,021 | $2.04 | $169,646.44 | -3.4% | +43.8% | - | |
| Mar 5, 2026 | STE Steris Plc | Feldmann Cynthia L55 | Director | Sell | 3,098 | $237.21 | $734,876.58 | -81.5% | -11.9% | - | |
| Mar 5, 2026 | ISRG Intuitive Surgical, Inc. | Brosius Mark56 | SVP &Chief Mfg And Supply Cha | Sell | 3,658 | $496.19 | $1,815,061.50 | -22.8% | -17.0% | - | |
| Mar 4, 2026 | TMDX Transmedics Group, Inc. | Weill David63 | Director | Sell | 3,571 | $146.82 | $524,294.22 | -22.7% | -53.7% | - | |
| Mar 4, 2026 | RSMDF Resmed Inc. | Farrell Peter C57 | Director | Sell | 2,000 | $260.22 | $520,440.00 | -3.1% | - | - | |
| Mar 4, 2026 | STIM Neuronetics, Inc. | MacAn William Andrew66 | EVP, CLO And Cs | Sell | 609 | $1.34 | $816.06 | - | +17.3% | - | |
| Mar 4, 2026 | NVCR Novocure Limited | Leupin Nicolas | Former Chief Medical Officer | Sell | 1,100 | $13.31 | $14,635.94 | -1.1% | +17.9% | - | |
| Mar 4, 2026 | TMDX Transmedics Group, Inc. | Lovell Stephanie | Director | Sell | 1,193 | $149.62 | $178,496.66 | -29.4% | -53.7% | - | |
| Mar 4, 2026 | TMDX Transmedics Group, Inc. | Hernandez Gerardo51 | Chief Financial Officer | Sell | 7,611 | $146.81 | $1,117,381.56 | -14.7% | -53.7% | - | |
| Mar 3, 2026 | CBLL Ceribell, Inc. | Chao Xingjuan51 | President And CEO | Sell | 39,000 | $17.45 | $680,564.46 | -1.8% | +5.2% | - | |
| Mar 3, 2026 | CBLL Ceribell, Inc. | Foehr David | Senior VP, Finance And Pao | Sell | 4,560 | $17.80 | $81,168.00 | -11.5% | +5.2% | - | |
| Mar 3, 2026 | CBLL Ceribell, Inc. | Robertson Rebecca B76 | Director | Sell | 827 | $17.80 | $14,720.60 | -4.2% | +5.2% | - | |
| Mar 2, 2026 | IRTC Irhythm Holdings, Inc. | Wilson Daniel G.63 | Chief Financial Officer | Sell | 3,395 | $128.45 | $436,076.41 | -2.2% | -11.3% | - | |
| Mar 2, 2026 | IRTC Irhythm Holdings, Inc. | Blackford Quentin S.60 | President And CEO | Sell | 13,813 | $128.44 | $1,774,173.93 | -2.2% | -11.3% | - | |
| Mar 2, 2026 | SINT Sintx Technologies, Inc. | Lyons Christopher Michael | Director | Buy | 8,292 | $2.91 | $24,092.28 | +1,094% | -20.6% | - | |
| Mar 1, 2026 | NMTC Neuroone Medical Technologies Corporation | Wambeke David J.67 | Chief Business Officer | Buy | 1,000,000 | $0.67 | $670,400.00 | New | +427.4% | - | |
| Feb 25, 2026 | PODD Insulet Corporation | Minogue Michael R | Director | Buy | 2,030 | $246.23 | $499,846.90 | +13.1% | -38.0% | - | |
| Feb 24, 2026 | SRTS Sensus Healthcare, Inc. | Sachetta Eric | Director | Buy | 2,000 | $3.81 | $7,620.00 | +1.4% | -16.7% | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.